BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35801573)

  • 1. Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx Cancer.
    Eita A; Mohamed N; Rybkin A; Kang JJ; Fiasconaro M; Zhigang Z; Zakeri K; Yu Y; Sadaka E; Sherman E; Dunn L; Cracchiolo J; Wong RJ; Cohen M; Lee NY
    Laryngoscope; 2023 May; 133(5):1138-1145. PubMed ID: 35801573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
    Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ
    Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus-associated squamous cell carcinoma of the larynx or hypopharynx: Clinical outcomes and implications for laryngeal preservation.
    Hughes RT; Beuerlein WJ; O'Neill SS; Porosnicu M; Lycan TW; Waltonen JD; Frizzell BA; Greven KM
    Oral Oncol; 2019 Nov; 98():20-27. PubMed ID: 31536842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited surgery for cancer of the larynx and hypopharynx: options and consequences.
    Nakayama M; Takahashi H; Yao K; Inagi K; Makoshi T; Nagai H; Okamoto M
    Acta Otolaryngol Suppl; 2002; (547):41-5. PubMed ID: 12212592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The results and toxicity of organ preservation treatment for locoregionally advanced laryngeal and hypopharyngeal cancer].
    Kiprian D; Kawecki A; Jarząbski A; Michalski W; Pawłowska-Sendułka B
    Otolaryngol Pol; 2011; 65(5):363-8. PubMed ID: 22078287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial.
    Ou X; Zhai R; Wei W; Chen J; Ou D; Liao T; Xu T; Zhu Y; Wang Y; Huang S; Shi R; Wu B; Chen T; Li Y; Yang Z; Zhou C; Liu Y; Jiang Z; Zeng M; Liu X; Ji D; Ying H; Zhang Z; Hu C; Lu X; Ji Q; He X; Wang Y
    Clin Cancer Res; 2024 Jan; 30(2):344-355. PubMed ID: 37955629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-surgical organ preservation in laryngeal and hypopharyngeal cancers: an audit from the clinic.
    Sood S; Sinha S; Balaji A; Mundhe SR; Mummudi N; Budrukkar A; Swain M; Prabash K; Noronha V; Joshi A; Patil V; Laskar SG
    J Laryngol Otol; 2023 Apr; 137(4):448-454. PubMed ID: 35678378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological results of surgical treatment versus organ-function preservation in larynx and hypopharynx câncer.
    Calvas OIJ; Ramos DM; Matos LL; Kulcsar MAV; Dedivitis RA; Brandão LG; Cernea CR
    Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1082-1089. PubMed ID: 29489975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
    Al-Mamgani A; Navran A; Walraven I; Schreuder WH; Tesselaar MET; Klop WMC
    Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):575-583. PubMed ID: 30564952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Tanaka N; Tanaka T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Sep; 34(9):5205-10. PubMed ID: 25202116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
    Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic Outcomes After Salvage Laryngectomy for Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study.
    Meulemans J; Debacker J; Demarsin H; Vanclooster C; Neyt P; Mennes T; Vauterin T; Huvenne W; Laenen A; Delaere P; Vander Poorten V
    Ann Surg Oncol; 2021 Mar; 28(3):1751-1761. PubMed ID: 32860174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Larynx and hypopharynx cancers--endoscopic surgery with laser: possibilities and limits].
    Rudert H
    Arch Otorhinolaryngol Suppl; 1991; 1():3-18. PubMed ID: 1867569
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor Volume Useful Beyond Classic Criteria in Selecting Larynx Cancers For Preservation Therapy.
    Sharrett JM; Ward MC; Murray E; Scharpf J; Lamarre ED; Prendes BL; Lorenz RR; Burkey BB; Koyfman SA; Woody NM; Greskovich JF; Adelstein DJ; Geiger JL; Joshi NP
    Laryngoscope; 2020 Oct; 130(10):2372-2377. PubMed ID: 31721229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the larynx as a last resort for oral intake in a hypopharyngeal cancer patient.
    Suzuki T; Imaizumi M; Kikuchi D; Sato K; Murono S
    Auris Nasus Larynx; 2022 Aug; 49(4):717-720. PubMed ID: 33455818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathomorphological aspects of transoral resection of hypopharyngeal carcinoma with preservation of the larynx. Patient selection, treatment results].
    Glanz H
    Laryngorhinootologie; 1999 Dec; 78(12):654-62. PubMed ID: 10666691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proposal for the management of epithelial carcinoma of the larynx and hypopharynx].
    Orv Hetil; 1989 Apr; 130(18):949-50. PubMed ID: 2726245
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiotherapy alone for early-stage squamous cell carcinoma of the larynx and hypopharynx.
    Foote RL
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S31-6. PubMed ID: 17848288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
    Guadagnolo BA; Haddad RI; Posner MR; Weeks L; Wirth LJ; Norris CM; Sullivan CA; Goguen L; Busse PM; Tishler R
    Am J Clin Oncol; 2005 Aug; 28(4):371-8. PubMed ID: 16062079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.